Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study! -- Ignore unavailable to you. Want to Upgrade?

To: Vol who wrote (5795)	11/7/1997 10:59:00 AM
From: Douglas Webb	Read Replies (2) \| Respond to of 14162

I think INVN might be the better buy. Their backorders represent some $47 million revenue for next year, and will have around $53 million revenue for this year, while BARR has no backorders, and about $21 million revenue for this year. Also, BARR's price is heading steadily down from it's high point this summer, and is near the upper BB now, which puts it at a high point in a larger downtrend. It might good for shorting or buying puts, but I wouldn't CC it. I'm still in the red on UGLY by $2 1/4 or so. It gapped down today, but seems to be coming back; I'm hoping it'll at least break even before the day is done. I'm split about 50/50 between UGLY and CREAF right now. If they both reach what VectorVest values them at ($24.50 for UGLY, $50 for CREAF) I'll have made 157% since starting this business in May, with a 75% gain in UGLY and 100% gain in CREAF. That'd be a lot better than my current 18% loss since May. Doug.